Coexistence of guanidinoacetate methyltransferase (GAMT) deficiency and neuroleptic malignant syndrome without creatine kinase elevation

Ayanoglu, Muge; Korgali, Elif; Sezer, Taner; Aydin, Halil; Sonmez, Fatma

doi:10.1016/j.braindev.2020.02.001

Coexistence of guanidinoacetate methyltransferase (GAMT) deficiency and neuroleptic malignant syndrome without creatine kinase elevation

Copy For Citation

Ayanoglu M., Korgali E., Sezer T., Aydin H. I., Sonmez F. M.

BRAIN & DEVELOPMENT, vol.42, no.5, pp.418-420, 2020 (SCI-Expanded)

Publication Type: Article / Article
Volume: 42 Issue: 5
Publication Date: 2020
Doi Number: 10.1016/j.braindev.2020.02.001
Journal Name: BRAIN & DEVELOPMENT
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, EMBASE, MEDLINE, Psycinfo
Page Numbers: pp.418-420
Karadeniz Technical University Affiliated: Yes

Abstract

We describe the first child with guanidinoacetate methyltransferase (GAMT) deficiency who developed neuroleptic malignant syndrome (NMS) after the treatment of risperidone without elevated creatine kinase (CK) levels.